MENU

CellFree Sciences, MOU Signed With CALICI | CellFree Sciences

header jp

header en

News

CellFree Sciences, MOU Signed With CALICI

Category: Press releases Created: Monday, 10 February 2025

CellFree Sciences-CALICI, Innovative Drug Development - Treatment Research MOU Signed

 

MOU 100

 

 

 

 

Accelerating Synergy in Innovative Drug Development between Korea and Japan

 

CALICI, a protein structure-based AI drug discovery (SBDD) company headquartered in the US and Korea, and CellFree Sciences (CFS), a Japanese company based in Yokohama known for its wheat germ cell-free protein expression technology and MaZiQ arrayTM system (an array of unmodified human genomic protein beads), recently signed an agreement and formalized their partnership.

This partnership aims to make breakthrough progress in the development of treatments for infectious diseases, metabolic disorders, and cancer through in silico and experimental protein interaction research, target validation/off-target analysis, and mechanism of action research by combining CALICI's expertise in AI modeling and drug candidate optimization with CFS's services for analyzing intermolecular interactions and proteomics profiling.

The two companies will act as mutual agencies for each other's services in Korea and Japan, and will promote cross-border collaboration and provide smooth customer access to innovative technologies. The two companies also began a non-public joint research.

“CFS's MaZiQ array® will validate the results of AI-designed drug candidates and add meaning to experimental success, and through this, our partnership will be able to provide new drug development companies with higher value-added services,” said CFS CEO Ozawa Satoshi.

Dr. Jae Moon Choi, CEO of CALICI, said, “This partnership symbolizes a new era of drug development, and aims to create synergies by combining the unique technologies of both companies to develop more efficient new drugs and treatments for diseases.” He added, “I expect that the two companies will be able to provide breakthrough solutions to both countries faster and more efficiently together.”

Meanwhile, CALICI was selected as the 6th Daejeon company for IBK Changgo, an innovative startup company development program run by IBK.

Copyright © CellFree Sciences Co.,Ltd. All Rights Reserved. [login]

We use cookies to ensure you get the best experience. By using our website you agree to our Cookie Policy.